| Q46492086 | 2,5-Hexanedione induced decrease in cytoskeletal proteins of rat sciatic-tibial nerve |
| Q35571766 | 2,5-hexanedione induced apoptosis in mesenchymal stem cells from rat bone marrow via mitochondria-dependent caspase-3 pathway. |
| Q42471125 | Cholinergic fiber perturbations and neuritic outgrowth produced by intrafimbrial infusion of the neurofilament-disrupting agent 2,5-hexanedione |
| Q23910047 | Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat. |
| Q47401759 | Decreased levels of the high molecular weight subunit of neurofilaments and accelerated neurofilament transport during the recovery phase of 2,5-hexanedione exposure |
| Q73342620 | Effects of 2,5-hexanedione on calpain-mediated degradation of human neurofilaments in vitro |
| Q49146481 | Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H. |
| Q34841278 | Fast axonal transport: a site of acrylamide neurotoxicity? |
| Q48806482 | Heterogeneous visceral nerve changes in acrylamide intoxication |
| Q40437595 | Immunohistochemical detection of the effects of toxic injury on the central nervous system |
| Q52529165 | Pathogenesis of two axonopathies does not require axonal neurofilaments. |
| Q48334409 | Quantitative alterations of S-100 protein and neuron specific enolase in the rat nervous system after chronic 2,5-hexanedione exposure. |
| Q48194935 | Time-dependent alteration of cytoskeletal proteins in cerebral cortex of rat during 2,5-hexanedione-induced neuropathy |
| Q44652910 | γ-diketone central neuropathy: quantitative morphometric analysis of axons in rat spinal cord white matter regions and nerve roots |